Search
for
Sort by
Research 30 of 359
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Dermatologic Reactions to Targeted Therapy
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Chemotherapy and Cutaneous Drug Reactions
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Isotretinoin treatment of acne and related disorders: An update
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Rosacea and Rosacea-like Demodicldosis